Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DuCord, the Duke University Cord Blood Bank, is a premier public cord blood bank and a global leader in the field of umbilical cord blood transplantation. Based at Duke University Medical Center, it was among the first facilities to receive FDA licensure for its hematopoietic progenitor cell (HPC) products. The organization specializes in the collection, processing, and cryopreservation of high-quality cord blood units for use in unrelated donor transplants. DuCord's mission is to provide life-saving stem cell products for patients with various hematologic, metabolic, and immune system disorders. Under the leadership of Dr. Joanne Kurtzberg, it remains a critical resource for the global transplant community and a pioneer in cellular therapy research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ducord.